Retired
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That should help our management find a way to exploit this already konown opportunity .
On FEB 21 (my Post# 4530) I alluded to this following the following news :' BEIJING, Feb 21 (Reuters) - China Customs has warned consumers from buying and eating some infant and baby products of Abbott.'
I then outlined an hypothetical scenario aimed at exploiting this opportunity rapidly, ‘IMAGINING’ some kind of WIN-WIN scenario for both our CEO and ABBOTT.
At the end of my post I ask 3 questions:
- How bad is ABBOTT hurt by recent news?
- How aggressive would ABBOTT want to be to get back (indirectly)
into its crippled market?
- How much does current management of ELSE want to remain totally
independent?
TODAY
Today the problem is not a company (ABBOTT) issue but an industry problem (read an even more incredible opportunity for ELSE).
I however ask myself if we were position to do it (by ourselves or with another company)?
It's in that context that I assumed to be a mother looking for a baby food products since I could not find my usual one. I went to Google to find altenatives:
Search 1: ‘baby food companies in usa’
https://search.yahoo.com/yhs/search?hspart=yahoo&hsimp=yhs-le5a&p=organic+baby+food&type=868547.0.10.99.5031198.28277.868547H99HA7ACjwKCAjwjtOTBhAvEiwASG4bCDqyIwfBU_9dlJNg32q-Ig9fplLMMnKdSjoYt00VmDnpV_PcyG7azhoCMWgQAvD_BwE.CA. … NO ELSE
Search 2:‘best organic baby food brands’
https://organicsbestshop.com/?utm_source=google&utm_medium=cpc&utm_campaign=COLD_CA_Domain-Targeting&utm_content=132289112818&utm_term=organic%20best&gclid=EAIaIQobChMI5PHJg_nK9wIVyvvICh3XzQHdEAAYASAAEgJRuPD_BwE …NO ELSE
…
Mothers do not know about ELSE (unless they read the CEO’s PR’s for shareholders) and cannot even find us as an alternative … even in USA (never mind worldwide)
.
Believing the KNOWN major manufacturers of our industry will sit on their hands doing nothing is crazy. The ongoing opportunity will not be there forever and the ABBOTTS, GERBERS, … (and mothers) will resolve their problem SOMEHOW, with or without us.
Will our CEO standby, happy with our ‘petshop’ type of revenues (more or less $10M in 2022), dreaming of becoming a billionaire company in some years from now … because we have a great product? Let's hope not
I believe that this stock has become the toy of a few traders and investors do not even touch it. Unless our management wakeup, the worst is ahead of us.
I do however believe that someone, sooner than later will get to our CEO and convince her to do the right thing.
Assuming our CEO gets that ???
Source: Harvard Business Authors:
Joan Schneider and Julie Hall, CEO and exev.VP of Schneider Associates, an integrated marketing and public relations agency.
Numerous factors can cause new products to fail.
The biggest problem we’ve encountered is lack of preparation. Companies are so focused on designing and manufacturing new products that they postpone the hard work of getting ready to market them efficiently until too late in the game.
Flaw 4 out of 5: The product defines a new category or specificity and requires substantial consumer education—but doesn’t get it.
If consumers can’t quickly grasp how your product is different, it’s toast.
“40 Ways to Crash a Product Launch.” If your company is guilty of ANY OF THESE, think about how to turn them around.
Way #2 out of the 40 ways: Most of the budget was used to create the product; little is left for launching, marketing, and selling it.
#11. The marketing campaign is developed in-house by the manufacturer and lacks objectivity.
#23. The launch budget is insufficient to “pull” the product off the shelf.
#24. The product has no trained spokesperson to educate the media.
#27. The ad campaign is untested and ineffective.
#28. The launch campaign depends solely on PR to sell the product.
#30. Company executives underestimate the value of Twitter and Facebook.
It has been proven time and time again that fot 1$ used to develop a product, one mus spend $1 in Marketing/advertizing.
To reach new mothers, you have to get to them where they are (with a new baby) and the way to do it is thru advertizing in medias. Our company has plenty of cash, no debt and ... no sales worth mentionning.
90%+ of their 'online advertizing' is generally aims at saying how great our sales generation is (???) with a CEO quote claiming to be proud. It's generally aimed at shareholders and in any case, new mothers do not spend a lot of time on Internet looking for new unknown products.
This being said, I have a feeling our CEO will keep believing the product will do the job and marketing/advertizing is not an INVESTMENT but an EXPENSE.
I'm now down to 20,000 shares (have been at 30,000 for a while) and honestly, the company will have a real problem keeping the ongoing market cap (More or less $150M) considering expected 2022 revenues (assuming 25% growth Q to Q) making our multiplier more or less 15.
Let's hope someone can convince that having a good product is only HALF THE RECIEPE to consider.
Try it and see
Definitely not procrastinating in what she does right (R & D) but she is relative to letting the market we aim at know we do exist.
Like your analysis of 'shoulda gone for a regional roll out with tons of marketing cover to generate SALES!!!!!!!!!!!!!! . This is an approach different than the one I suggest but iwould have been a great one also.
Unfortunately (I stand to be corrected) HAM is someone believing (like in having faith) that the great product is all one need to be successful. I've met some people like that in my carreer. Most failed, few made a minimal success before they were bought for cheep.
ROT: To be successful a company mus spend $1 in Marketing (mainly advertizing in our case) for every $ that was spent to create a product.
Thanks I did use it
I do not mind being patient but am not when I witness procrastination.
Relative to General Mills, that is a marketing success story to look at:
https://www.generalmills.com/how-we-make-it/responsible-marketing-and-advertising
Marketing & Advertising
We are committed to maintaining the highest standards for responsible marketing.
What is general marketing strategy?
A marketing strategy refers to a business's overall game plan for reaching prospective consumers and turning them into customers of their products or services. A marketing strategy contains the company's value proposition, key brand messaging, data on target customer demographics, and other high-level elements.
A little learning of understanding what you read could be helpful.
1 - I said again and again I do respect our CEO and never said having paediadic doctors around was negative. One part of the company is (efficiently) doing R&D relative to developping nutrition products for baby and therefore such advisors are extremely valuable.
2- As for 'speaking directly with new mothers', I obviously did not hint that our CEO should speak DIRECTLY wit new mothers (what a crazy idea). I said again and again that focussing somewhat on Marketing, including advertizing is required. I do not expect our CEO to do it by herself (Heck is that a 'one woman show?) but maybe adding a some MARKETING SKILLED people and qualified advisors to her team could help her (and us) be a lot more successful, faster (i.e. before competition catch up). Do not ask me to contribute to developping products (not my skills) but as for marketing 101 to 199, I do not need a lesson by someone not understanding the ART.
3- Finally, having a great offering or product is half the story (that we have). Getting the attention of users aimed at is the other half. Many that forgot that lesson did fail miserably. I hope that idea gets the attention of our CEO sooner than later or even to late.
GLTA
Thanks. Can you send me his email address?
One analyst Cannaccord) follows our company.
- May 3, 2021: Canaccord Genuity lowered its 12-month price target from C$6.50 to C$5.75 and reiterating its speculative buy rating.
- Dec 6, 2021: Canaccord Genuity lowered their 12-month price target to C$4.00 from C$5.75.
To my knowledge Cannaccord still hasn't issued their conclusions following Q42021 and FY2021 results ???
As of today, Morningstar quote the FAIR VALUE of the stock at $2,65
I wonder: does our CEO see that her satisfaction with a revenue growth of 25% Q to Q is a sentiment that is not shared by those following the company?
Who does our CEO discuss with (Scientific Advisory Board)?
- Professor Vanderhoof, Pediatric gastroenterologist at Boston Children's Hospital, Senior Lecturer in Pediatrics at Harvard Medical School. Prof. Vanderhoof is a Pediatric Gastroenterologist in Boston, at Boston Children's Hospital, a Senior Lecturer in Pediatrics at the Harvard Medical School, and Professor Emeritus of Pediatrics at the University of Nebraska College of Medicine.
- Yvan Vandenplas did his medical studies at the ”Vrije Universiteit Brussel” and trained in pediatrics (1981-1986) at the same University. He became Head of the Unit for Pediatric Gastroenterology and Nutrition in 1987 and is Head of the KidZ Health Castle, at the University Hospital Brussels and has the Chair of Pediatrics since 1994. He has more than 500 publications listed in Medline. His main interests are infant nutrition, gastro-oesophageal reflux and functional gastro-intetsinal disorders. He is now associate editor of the Journal of Pediatric Gastroenterology and Nutrition.
- Prof. Shamir is the Chairman of the Institute of Gastroenterology, Nutrition and Liver Diseases at Schneider Children’s Medical Center of Israel, and is a Professor of Pediatrics at the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel. He is the past President of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), published more than 250 original papers, reviews and comments, book chapters and guidelines, and serves as an Editor for the pediatric section of Current Opinion in Clinical Nutrition and Metabolism, is the Senior Associate Editor of the Journal of Pediatric Gastroenterology and Nutrition (JPGN), and serves as a reviewer for journals in the field of Pediatrics, Nutrition, Gastroenterology and atherosclerosis.
Seriously, This is quite a team to work with BUT: 'How much time does our CEO spend discussing MARKETING with her advisory board?
I personally believe that she is being told the same thing I keep saying, by many around her but (as often the case with scientific leaders) she thinks she knows better and stubonrnly just does not listen. Does anyone think she is not aware of the posts herein (including mine obviously)?
What is frustrating is that the baby food industry is CURRENTLY in some kind of limbo and Else has an incredible story to tell. Unfortunately our approach to the market is seriously deficient and madam 'mother of a newborn' doesn't even know that Else exist. Even large investors do seem to sit on the sideline wanting to wait and see if we will start doing the right thing.
How many new mother do you think read Canada newswire to find out that Else even exist? Not knowing it does exist, how can they order it from Amazone or other distributors?
How much did the company spend in general public medias, advertizing our unique offerings directly to mothers wanting the best for their kids? It looks that our scintific CEO prefer to talk with pediatric doctors than to new mothers directly.
Do not take me wrong, I respect our CEO for what she is good" I however do much less for her lack of recognizing that she doesn't have all the answers to all aspects of making a success of her project.
I bet half my shares that many already did try to explain that to her and honestly do not believe I would even be welcome (pro Bono or not) to talk to her.
This is becoming a great opportunity and major gains are ahead in 2022
Morningstar evaluation reads:
Technical analysis:
Short term (2 to 6 week) expectation: Somewhat negative
Medium term (6 weeks to 9 months): Somewhat positive
Estimated fair value (current): CDN $0,83
Having more shelves isn't bad obviously but an 'a TV or mediatic add campaign' is more than needed. I just hope our CEO think so but ???
The most obvious 'some peoples' you seem to refer to claims not to be a shareholder anymore. Therefore Leon cannot use that excuse to keep keeping us (real shareholders) in the complete darkness.
Letting our pps fluctuate at + or - $0,0006 or so and accepting to let the MC stay at less than $2,500,000 is unacceptable. I cannot figure out why our CEO acceptsthat situation silently. I prefer not to document what I think does explain that behavior.
Let's hope Leon soon decide to come out of his inexplicable silence.
Bought some shares and was looking for information thru this message board. After few days it was obvious that our board is useless, highjacked by tiny shareholders posting a lot of useless messages.
Honestly, Leon's behavior and attitude toward his shareholders is disastrous.
Not outlining a serious factual corporate update at this time is either irresponsible or motivated by unexplained justification he may secretely have.
For one, I sit on my share believing (???) he knows what he does but didn't have those shares I would not even consider buying some, even at current price.
Let's hope someone can make Leon come out of his disastrous hiding.
She keeps doing the same thing (putting it available and affordable) but has no Marketing activity worth mentionnong.
All PR's do mention availability, accessibility and include a comment by our CEO.
THE ISSUE IS that people can walk by the product on the shell but do not know anything about it.
How, when the industry (Baby food) goes to such a turmoil ('poisonned' food) don't we see 'ADVERTIZING' outlining the quality of our products.
Any CEO knowing what we offer and having any sensitivity to 'MARKETING' would already have a massive ADVERTIZING campain alerting the market to our 'revolutionary' offering.
Our CEO (No doubt brilliant relative to her R&D skills) seems to think MARKETING is a unnecessary expense. She thereby are proud to see sales measured in the single digit number of dollars per quarter instead of in 3 digit number per quarter.
Let's hope someone around her can help her open her mind to business skill other than those she obviously have.
TIME IS OF THE ESSENCE.
'... their inconsistent press releases.
'Remember the December 2019 press release ... '
'... coming in January 2020.'
'Less than eight weeks into 2020 ...'
You forgot what happenned between 2017 and 2019.
By the way, since these facts you feel relevant:
- They created a profitable operation
- They got their services licensed
- They now are generating revenues at the rate of $5,000,000 ($0 one year ago)
- Leon committed to grow the business even more (He knows what he does)
- Leon has stopped increasing the debt (even reduced it somewhat.
Ho by the way, these only are CURRENT FACTS we know about.
Some like to look at the trees (tactical analysis) but I think Leon is looking at the forest (strategic plan).
Time is of the essence and having a few thousand $$$ (3,000,000 shares) sitting in here may very well be extremely rewarding by early 2023 or so.
Leon seems to have a strategy …
Does anyone believe that he is not aware of the following and not working toward profiting from these program?
March 1, 2022: President Biden is laying out a vision to transform how mental health is understood, perceived, accessed, treated, and integrated – in and out of health care settings. The American Rescue Plan laid the groundwork, providing critical investments to expand access to mental health services.:
- Federal Role in Funding Services. The federal government is a major funding stream for mental health services. In addition to funding mental health services that fall under Medicare and the Department of Veterans Affairs (VA), it matches state Medicaid spending from between 50 to 70 percent. The federal government also provides Mental Health Block Grants that support states in building out their community mental health services. It supports funding services and advocates for expanded and sustained funding for mental health services.
- All states receive federal support via Mental Health Block Grants and partial funding of services provided through Medical have freedom in designing and funding its mental health system..
Then: Wednesday, April 27, 2022 HHS’s New Mental Health and Substance Use Disorder Benefit Resources Will Help People Seeking Care. New Resources made available to Help People Seeking Care to Understand care and Protections Offered for Mental Health and Substance Use Disorder Benefits.
Assuming he is smart, he must have someone working on hese sources of financing but first be recognized as a competent quality service supplier.That why he said (a doesn't say much person) in the last PR: “Our revenue growth for ARIA is a standout. The revenue improvements are a direct result of building a REPUTATION OF QUALITY CARE''.
Time is of the essence with this (still risky) investment.
'future value of the Company.' ... My concern is the definition of 'Future'. The world (read:competition) will not wait for us to get our fair share of the market. Just putting product on shells waiting for people to find it is not 'MARKETING' our CEO must figure that out sooner than later.
Let's remember the context of current forecast:
BABY -onference18-11-2021
*Going to be in 7 largest markets on Amazon EU in Q1 2022 (UK, Germany, France, Netherlands Sweden ect...) targeting 300 million people
*In talks with dozens of US retailers representing a point of no less than 30,000 points of sales
*Walmart and Kroger in a week or two
*Already producing Else for Canada in December to start selling in Q1 2022
*China is 45% of all global baby food market, 2022 (in talks with the largest e-commerce in China, announcing soon.)
*Pilot study, Else improves growth in children, GI symptoms, bowel movements improved up to 85% to 100% recovery)- they get to put results on the product!
*reaching 80,000 pediatricians to create growth engine for Else, started a month ago
*"Empire's take time to build" - CEO
*"Big things happening in 2022" -CEO
*2021 "was a year of laying the foundation for growth"
*"Very profitable in next 2-3 years"
* NASDAQ uplisting dependent on growth first and maybe next year...
*listed on TSX in CANADA Jan 20, 2022
*they will be diluting again, they have 23 million in cash right now =(
*lumping issues completely resolved on kids, changed instructions on toddler formula on how to dissolve powder
*FDA approval - clinical trial starts March 2022, ends in Q3 2023 (yikes, but okay)
*inflation hasn't affected their suppliers for almonds, tapioca, and buckwheat
*shipping has gone up but not dramatic enough to hurt Else
*Amazon EU will be smooth because they have had practice with Amazon US
*Else will be cash positive most likely 2-3 years from now
*30-40 SKUs dropping next year, US 11 SKUS, EU 11 SKUs, Canada, China
*expanding scientific advisory board, even more, to help get permit from the FDA
*No plans to split shares on uplisting
*They are making prototypes on Else bars (it's in the works)
*Else does not want to be a manufacturing company but they will own their own equipment.
*Airing a commercial in Q1 2022, once more SKUS come out (want to be on as many shelves as possible before TV)
*gross margins now are low 30's and are anticipating low 50's by 2024
*China's marketing strategy will be more on functionality, digestible, and gentle the formula is. China's babies are more prone to allergic and intolerance to dairy is greater than anywhere else in the western world
*they are going to partner with someone in China and create a team to market there, they also will work on products specifically for China down the road
*Europe, start with Amazon, then possibly getting into the pharmacy space there (Nice!)
*They have direct communication with Whole Foods in the US, they are planning to get there very soon
*Else has about 30-32 total employees
*partnering with the largest almond grower in CA(Else has its own orchard there), no limitation of almonds as far as next 5 years time
*Yes on strategic partnerships on the horizon, she can't talk about it
*no revenue guidance because they haven't had time to trend the velocity, and they need time to get to a revenue trend and need more data and selling products longer.
They now (5 months later) have more data and have been selling relatively much longer.
On March 31st, 2022, the Company released its 2021 annual results and expectations for 1Q22 revenues to be in the range of C$1.45M to C$1.6M, representing a 15% to 25% sequential increase versus 4Q21. The Company now expects to be at the top end of this guidance range.
The Company anticipates continuing its revenue growth in 2Q22 with expectation of revenues to range between C$1.8M and C$2.0M.
At that rate of growth let's say 25% per Q every quarter during the next 3 years,
FY 2022 will generate revenues of CDN $10M
Fy 2023 will show revenues of CDN $21M (,3, 3.9, 4.9, 6.1)
Fy 2024 : CDN $45M (7,6, 9,5, 12, 15)
Personally considering the market available, the difficulties of competition in this market and the product we offer, these projections are totally non acceptable. Our MARKETING FORCE is obviously not appropriate. Buyout, merger, partnerships, ... are opportunities to consider and I suggest our management now must acquire help (consulting) to review its ongoing strategies. The outlined growth forecast would be great for many but BABY must be more aggressive and cannot accept that considering the offer it has.
By the way, large competitors will not sit on their hands and they will develop and offer more competitive products.
3 years from now what kind of market cap can we expect (What will O/S be by then).
Right now our MC is more or less CDN $150M (expected FY2022 Revenues of $10M X 15).
Management must stop satisfying itself with what they curently do and work at becoming more productive, faster.
I'm now stuck with 100,000 close to worthless value but I also think the company is trying to relaunch but I do not know in what context.
I honestly think management doesn't care about its shareholders and the value of their stock. Were they somewhat responsible people, they would (WITHOUT UNDUE MISLEADING PROMISSES) issue some kind of Corporate update describing honestly the current state of the company and the plans the management does try to realise.
As in many such stocks however, management has absolutely no respect to their shareholders and informing them APPROPRIATELY is not something they do care about.
I own only 2 OTC stocks and I intend to never buy another one, this market being made from irresponsible companies managements and worst even being manipulator by some, exploiting this crazy behavior at the cost of small hopeful investors.
OTC is a crappy unregulated market and playing roulette in a casino is offering as good a reward potential (negative or positive), faster.
I was not stupid enough to bet the rent money ... Thanks God.
GLTA, ... spin the wheel
Hard to be confident with no way to really know what is going on behind the doors.
The only positives I have are:
- Recent purchase of a business
- Current market cap at just ove CDN$ 8M (US$ 6M)
- Morningstar still showing a 'fair value' of the stock at CDN $,012 (twice current pps).
Whatever goes on OR NOT behind the walls is a very well kept secret. I regret having bought these shares ... at least currently.
Leon did meet his legal obligation by filing in time but was smart enough not to issue whatever comments he may have just before a long weekend.
I hope (even believe) that Leon will issue an update of the situation early next week when peple are back and already aware of the filing.
If I did not believe in the POTENCIAL of this company, I would not be that much invested in it.
This being said, one has to be blind not to see that the last 5 Q's (I include Q1FY22 assuming the CEO knew what she said ... $1,45 to 1,6M) did show EXTREMELE SMALL revenues.
Whoever is around our CEO may be able to help her (if they are marketing concious 'advisors') but then, THE BOSS may have an open ear and listen to them. For the moment she seems to believe that having few products on many shelves will make it. As I said she is a great 'scientific' person but I want to understand that she intend to do do develop her (our) markets.
Right but that doesn't change the said story.
This is only an illustration of a case similar (changes required) but also different (Else profitability is not the issue) from our situation.
I own another small stock (also listed on TSXV) from a young plant food business that had to FUNDAMENTALLY REALIGN ITS STRATEGY..
Less than 2 years hold, this company had a different problem to result but they addressed it for what it was. Their problem was thew grew revenues rapidly (4 times what Else’s were Q4FY21) but important financial losses.
Accepting something was wrong, the board recently made fundamental changes in there organisation impacting the organizational, financial, operational and strategic decisions of the company.
The president of the company said: ‘The company is at an important juncture, and we are taking decisive steps. Our focus is to continue to build on our brand and reputation and grow our market share in the plant-based meat segment while optimizing our operations towards a path to profitable growth.The company is implementing cost improvement measures as it transitions from a focus on top line growth, to a focus on achieving sustainable, profitable growth.’
Some of the recent steps taken included:
- Termination of the CEO (The search from a new one is going on)
- Acceptation of the resignation of their Chief R&D officer
- Right-sizing of the organization through a workforce reduction
- Nomination of a company's Chief Commercial Officer.
- Nomination of a Vice President of Sales
- Nomination of a Vice President of Operations.
Else problem is different for sure but executives of the company must accept that they have a serious issue (revenue growth) that they also have to address. More of the same will only be leading to loss of the opportunity.
Have a nice sleep
Again, today’s PR is announcing that additional shelves are being created (sure that this does address our PROBLEM). HERE IS WHAT OUR PROBLEM IS:
Last December 6, Canaccord’s updated its full-year 2022 revenues estimate … following publication of Q3FY21FINANCIALS.
Expected Revenues FY2022 outlook:
Cannaccord admited that now that the company has a few quarters of data, their market penetration estimates had to be cut by roughly 25% in every category:
? Infant complete nutrition: Reduced from 15.0% to 11.5%
? Toddler complete nutrition: Reduced from 10.0% to 7.5%
? Baby complementary nutrition: Reduced from 3.5% to 2.5%
? Children/kids complete nutrition: Reduced from 2.0% to 1.5%
Canaccord’s therefore updated its full-year 2022 revenues estimates as follows:
- Initial Expected Revenues FY2022 were: $49,572,000
- Expected Revenues FY2022 became: $19,580,000 (Delta -60,5%)
Remember, that was based on Q3FY21FINANCIALS.
(source: https://thedeepdive.ca/else-nutrition-canaccord-cuts-price-target-after-another-quarter-of-estimate-misses/)
Up to now, Canaccords did not (to my knowledge) repeat that exercise following yearend results. However, Q4 results being out, our CEO herself seems proud to say that Q1FY2022 Revenues (BEST CASE) may be $ $1,600,000 a best case growth of 25% from Q4FY2021 (She alude to revenues of $1,450,000 a 15% growth.
Let's be optimistic ???.
Even assuming a Q-to-Q growth of 25% Q-to-Q in 2022, starting with a Q1 of $1,600,000, that would not even make FY2022 Revenues $10,000,000 (this is 50% of the 60% downgraded estimate Cannaccord made 4 months ago.
I hope our CEO (or someone around her) realises AND ACCEPTS that possibility even more certainly it's more than time to figure out what has to be done, to stop heading right into a wall, soon.
I hope that our CEO finally see that her dream of $5,000,000,000 revenues in now less than 5 years will soon become a nightmare, if she doesn’t find help from qualified people, finally accepting that ‘good product only’, whatever the number of shelves it sits on, cannot make it.
I however worry that she may not be that openned to the idea that: To be successfull, Else cannot be a toy she doesn't have to share.
Let us prey
If I tought that Leon was the crazy or worst person a certain expert seems to believe him to be, I would not hold millions of shares. I however understand that playing with an OTC pinky is not the same as investing in a blue chips. Hard to believe that someone would be (pick your qualifier) enough to not understand that.
Anyone believing this to be a scam, should not hold shares and (my personnal view) when I do not hold shares in a stock, I do not spend my life following a message board covering it ???
Let's be honest and accept that:
- GRST is a risky pinky offering great gain potential,
- GRST is traded on a dangerous market, manipulated by some,
- GRST has reduced debts and did grow revenues,
- GRST is managed by a successful executive who doesn’t try to BS people,
- GRST’S CEO is having significant initial success at reviving a company that was in a deep coma only months ago.
No problem. Thanks for specifying.
Board monitors are sensitive. That they remove my post is ok (I should not have made a negative critic maybe) but removing the serious question from someone asking me if I lost money in BOON should have stayed (my opinion).
The answer to the question is (just in case):
Not a trader by definition (I invest) I always have a pinky 'toy' I play with (small money) making my days more interesting (following investments sometime feels like looking at grass grow.
With Boon I bought once (low) sold once High then bought again (low). I now only have 1,000,000 shares and my net cost is now 0,0011/sh. I presently have an open sell order at a high (?) price (0,0025) for all my shares.
If I get it, I walk away with a net gain of CDN$ 1,800. If the thing blows out in smoke, I would lose more or less $ 1,000.
If news comes out I can take out my open order and wait a bit.
Who knows, sometime the 'Roulette' stops on the right number ???
I hope (but doubt a lot) our CEO will figure out that she needs help. Unfortunately, she may very well be (I hope not) the type of brilliant person (scientifically) believing she knows better than anyone.
After 4 consecutive Q's in 2021 showing less than $1,3M in gross revenues, one must hope she did figure out that her dream may rapidly become a nightmare. I hope she starts figuring out that the following is being proven wrong:
'Hamutal Yitzhak, Else CEO, commented: “Else is a company that should not yet be measured solely by Quarters. We are building a pathway to be a potential global leader in the plant-based nutrition arena and aiming for a multibillion-dollar market in 5 years. We are making great strides each quarter.' (https://finance.yahoo.com/news/else-nutrition-reports-third-quarter-220600383.html
Someone shall remind her that the quarter thereafter (Q4FY21) did show no progress and she now may show close to no serious progress in Q1FY22. She herself said that the Q1FY22 may show revenues of 1,45 to 1.6 million dollars. Some petshops generate more revenues than that ($125,000/week).
Obviously Leon believes that, being in the process of ressussisating an almost dead business doesn't create many opportunities to issue significant developments on a regular basis.
He obviously believes that issuing quaterly financials and outlining where he stands in his project, is enough (That does frustrate me also but that's better than getting continuous insignificant or worst, misleading PR's).
I may not like it but I believe Leon to be a serious business man trying to create something worth being part of.
Let's see what the next few days do show ???
This again let me believe that Else is a one woman show lacking many skills needed to succeed. She obviously believe that a definition of the PRODUCT and how it's made is enough for the company to succeed. Again, she demonstrate that she has no understanding of what MARKETING is all about.
As a matter of fact I suspect that for her, the ART OF MARKETING is something that is a useless financial expense. She obviously do not understand that effective marketing is a 'make-or-break' requirement in businesses. She believes that having a good product, GIVEN TIME (5 years in her case), success will happen (1 Billion $$$ in her case).
It's been proven time and time again that it's really impossible for any company to be successful without good marketing, sales skills and techniques aimed at generating revenues. The alternative is FAILURE and it has been proven time and time again.
Marketing is more than simply letting people know about your products and how i's made (Most of this morning message). It's about anticipating and answering the needs of your target customers and markets.
To succeed, (I almost wrote: whatever the product) you need to be able to communicate to them exactly WHY THEY NEED WHAT YOUR BUSINESS CAN PROVIDE. And, then you have to REACH THEM with that message (Amateur self made poor message on Youtube is not it).
Considering the quality of what has been created (remember BETAMAX) it's extremely frustrating to look at our CEO proves that she believes she can do it all without investing seriously in MARKETING RESSOURCES ... The action or business of promoting and selling products or services, including market research and advertising ... (Source: OXFORD)